New Ebola vaccine made by team behind Oxford/AstraZeneca Covid vaccine starts human trials
Human trials begin for a new Ebola vaccine developed by Oxford/AstraZeneca Covid team The phase I trial is currently being conducted by 26 individuals. Expected results in six months Ebola…
